

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 6.02558980 |
| 2 | response to peptidoglycan (GO:0032494) | 5.56711072 |
| 3 | negative regulation of interleukin-12 production (GO:0032695) | 5.45031587 |
| 4 | immunoglobulin mediated immune response (GO:0016064) | 4.91955041 |
| 5 | macrophage activation involved in immune response (GO:0002281) | 4.88999559 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.85456507 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 4.85456507 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.85456507 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.85456507 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.85456507 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 4.85456507 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.75713007 |
| 13 | negative regulation of cell killing (GO:0031342) | 4.41953011 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.41953011 |
| 15 | detection of other organism (GO:0098543) | 4.32093097 |
| 16 | regulation of mast cell degranulation (GO:0043304) | 4.22191084 |
| 17 | detection of bacterium (GO:0016045) | 4.21586579 |
| 18 | positive regulation of mast cell degranulation (GO:0043306) | 3.92893381 |
| 19 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.92893381 |
| 20 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.92265615 |
| 21 | positive regulation of mast cell activation (GO:0033005) | 3.92025118 |
| 22 | granulocyte activation (GO:0036230) | 3.85591602 |
| 23 | detection of molecule of bacterial origin (GO:0032490) | 3.81040471 |
| 24 | myeloid cell activation involved in immune response (GO:0002275) | 3.76526638 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.75790771 |
| 26 | detection of external biotic stimulus (GO:0098581) | 3.74780297 |
| 27 | B cell mediated immunity (GO:0019724) | 3.69082680 |
| 28 | neutrophil activation (GO:0042119) | 3.66799157 |
| 29 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.62575186 |
| 30 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.62122526 |
| 31 | regulation of leukocyte degranulation (GO:0043300) | 3.60345642 |
| 32 | regulation of mast cell activation (GO:0033003) | 3.47729625 |
| 33 | response to muramyl dipeptide (GO:0032495) | 3.47463071 |
| 34 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.46438669 |
| 35 | macrophage activation (GO:0042116) | 3.42905432 |
| 36 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.38989411 |
| 37 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.38232643 |
| 38 | regulation of gamma-delta T cell activation (GO:0046643) | 3.36908072 |
| 39 | positive regulation of antigen processing and presentation (GO:0002579) | 3.36250331 |
| 40 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.35582726 |
| 41 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.35395395 |
| 42 | myeloid dendritic cell differentiation (GO:0043011) | 3.35069639 |
| 43 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.32905132 |
| 44 | detection of biotic stimulus (GO:0009595) | 3.31994287 |
| 45 | positive regulation of leukocyte degranulation (GO:0043302) | 3.31880884 |
| 46 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.29410331 |
| 47 | microglial cell activation (GO:0001774) | 3.28905747 |
| 48 | regulation of antigen processing and presentation (GO:0002577) | 3.27981006 |
| 49 | respiratory burst (GO:0045730) | 3.25489490 |
| 50 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.25388826 |
| 51 | response to host immune response (GO:0052572) | 3.25388826 |
| 52 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.24912029 |
| 53 | amino sugar catabolic process (GO:0046348) | 3.22678899 |
| 54 | defense response to protozoan (GO:0042832) | 3.21300496 |
| 55 | myeloid dendritic cell activation (GO:0001773) | 3.20344557 |
| 56 | NIK/NF-kappaB signaling (GO:0038061) | 3.15847832 |
| 57 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.11577937 |
| 58 | glycosphingolipid catabolic process (GO:0046479) | 3.10953081 |
| 59 | type I interferon signaling pathway (GO:0060337) | 3.09033868 |
| 60 | cellular response to type I interferon (GO:0071357) | 3.09033868 |
| 61 | leukocyte aggregation (GO:0070486) | 3.08375158 |
| 62 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.08362573 |
| 63 | response to protozoan (GO:0001562) | 3.07965907 |
| 64 | cellular extravasation (GO:0045123) | 3.06434282 |
| 65 | T-helper 1 type immune response (GO:0042088) | 3.05631541 |
| 66 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.05567754 |
| 67 | response to type I interferon (GO:0034340) | 3.04578737 |
| 68 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.00574605 |
| 69 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.99869815 |
| 70 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.97221429 |
| 71 | regulation of T cell tolerance induction (GO:0002664) | 2.97163749 |
| 72 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.96909344 |
| 73 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.96395985 |
| 74 | regulation of mononuclear cell migration (GO:0071675) | 2.96310562 |
| 75 | regulation of hypersensitivity (GO:0002883) | 2.96120290 |
| 76 | regulation of regulated secretory pathway (GO:1903305) | 2.94359035 |
| 77 | positive regulation of isotype switching (GO:0045830) | 2.94358316 |
| 78 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.93952833 |
| 79 | response to host (GO:0075136) | 2.93952833 |
| 80 | response to host defenses (GO:0052200) | 2.93952833 |
| 81 | positive regulation of humoral immune response (GO:0002922) | 2.87230591 |
| 82 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.85885940 |
| 83 | regulation of macrophage chemotaxis (GO:0010758) | 2.85714604 |
| 84 | positive regulation of type 2 immune response (GO:0002830) | 2.85264688 |
| 85 | myeloid leukocyte activation (GO:0002274) | 2.84123323 |
| 86 | oligosaccharide catabolic process (GO:0009313) | 2.81751549 |
| 87 | germinal center formation (GO:0002467) | 2.81184859 |
| 88 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.80761285 |
| 89 | positive regulation of B cell mediated immunity (GO:0002714) | 2.80761285 |
| 90 | leukocyte degranulation (GO:0043299) | 2.79746710 |
| 91 | regulation of tolerance induction (GO:0002643) | 2.79483829 |
| 92 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.79216961 |
| 93 | regulation of interferon-alpha production (GO:0032647) | 2.77084373 |
| 94 | glycolipid catabolic process (GO:0019377) | 2.76247081 |
| 95 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.76003989 |
| 96 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.73817829 |
| 97 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.73608306 |
| 98 | negative regulation of T cell mediated immunity (GO:0002710) | 2.73523808 |
| 99 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.72913878 |
| 100 | negative regulation of innate immune response (GO:0045824) | 2.71815160 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.47126073 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.03585392 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.02709534 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.64958487 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.58619274 |
| 6 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.45933229 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.20720757 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.06132990 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.92407241 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.86115380 |
| 11 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.75757852 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.73845924 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.71646403 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.69385826 |
| 15 | SPI1_23127762_ChIP-Seq_K562_Human | 2.50728973 |
| 16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.49037856 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.47717225 |
| 18 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.46729761 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.36438298 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.33501051 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.31467062 |
| 22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.14703279 |
| 23 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.13100856 |
| 24 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.07519236 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.06495508 |
| 26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.05168974 |
| 27 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04207517 |
| 28 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.01383060 |
| 29 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.01283887 |
| 30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.00218072 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.92597333 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.90430286 |
| 33 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75354657 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 1.75136614 |
| 35 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.72985951 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 1.68967957 |
| 37 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.67386191 |
| 38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.67215941 |
| 39 | UTX_26944678_Chip-Seq_JUKART_Human | 1.67126727 |
| 40 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.66716513 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.55213404 |
| 42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.54737530 |
| 43 | MYC_22102868_ChIP-Seq_BL_Human | 1.53924918 |
| 44 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.51573831 |
| 45 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.51469389 |
| 46 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.50991930 |
| 47 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47161947 |
| 48 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.46590449 |
| 49 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.44795274 |
| 50 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.43190849 |
| 51 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42752122 |
| 52 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40920357 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.40358996 |
| 54 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.39049017 |
| 55 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37879688 |
| 56 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.36514176 |
| 57 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.35648217 |
| 58 | * MYB_26560356_Chip-Seq_TH1_Human | 1.34931255 |
| 59 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34672476 |
| 60 | MAF_26560356_Chip-Seq_TH2_Human | 1.34455661 |
| 61 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32742761 |
| 62 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32428052 |
| 63 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31061296 |
| 64 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30251856 |
| 65 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.29307157 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.27919867 |
| 67 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.27565434 |
| 68 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.26698697 |
| 69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26697378 |
| 70 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22905795 |
| 71 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.19315825 |
| 72 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.19190171 |
| 73 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17889208 |
| 74 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.16226057 |
| 75 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15258301 |
| 76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14393900 |
| 77 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.14318793 |
| 78 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.09357725 |
| 79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07701729 |
| 80 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.06514331 |
| 81 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05715880 |
| 82 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05596819 |
| 83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.04469037 |
| 84 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03435203 |
| 85 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.02791299 |
| 86 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02301425 |
| 87 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.97694646 |
| 88 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.97492447 |
| 89 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96872181 |
| 90 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96635864 |
| 91 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96228538 |
| 92 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93187873 |
| 93 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.91972975 |
| 94 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91736935 |
| 95 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91413799 |
| 96 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.86907958 |
| 97 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.85241287 |
| 98 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.84801657 |
| 99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83953940 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.83105652 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.06176116 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.96112412 |
| 3 | MP0003436_decreased_susceptibility_to | 3.80544255 |
| 4 | MP0006082_CNS_inflammation | 3.64091462 |
| 5 | MP0003724_increased_susceptibility_to | 3.46207838 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.24374081 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 3.07327569 |
| 8 | MP0002419_abnormal_innate_immunity | 3.06558633 |
| 9 | MP0009785_altered_susceptibility_to | 2.99201512 |
| 10 | MP0009840_abnormal_foam_cell | 2.94959584 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.73541970 |
| 12 | MP0005387_immune_system_phenotype | 2.71853189 |
| 13 | MP0001790_abnormal_immune_system | 2.71853189 |
| 14 | MP0005671_abnormal_response_to | 2.67585967 |
| 15 | MP0005025_abnormal_response_to | 2.67428739 |
| 16 | MP0000685_abnormal_immune_system | 2.51572820 |
| 17 | MP0003172_abnormal_lysosome_physiology | 2.51511486 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.39312253 |
| 19 | MP0001800_abnormal_humoral_immune | 2.35592270 |
| 20 | MP0002723_abnormal_immune_serum | 2.34343956 |
| 21 | MP0004510_myositis | 2.31369405 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.29576109 |
| 23 | MP0002139_abnormal_hepatobiliary_system | 2.24171113 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 2.21142520 |
| 25 | MP0002420_abnormal_adaptive_immunity | 2.16522146 |
| 26 | MP0001819_abnormal_immune_cell | 2.13981080 |
| 27 | MP0001533_abnormal_skeleton_physiology | 2.05398908 |
| 28 | MP0003075_altered_response_to | 1.98459843 |
| 29 | MP0009278_abnormal_bone_marrow | 1.94266406 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.91857735 |
| 31 | MP0000343_altered_response_to | 1.87724393 |
| 32 | MP0009764_decreased_sensitivity_to | 1.78886638 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.76312598 |
| 34 | MP0002405_respiratory_system_inflammati | 1.74498179 |
| 35 | MP0003183_abnormal_peptide_metabolism | 1.71590727 |
| 36 | MP0003806_abnormal_nucleotide_metabolis | 1.70750128 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.70229944 |
| 38 | MP0008260_abnormal_autophagy | 1.70015727 |
| 39 | MP0001853_heart_inflammation | 1.68291983 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.67836387 |
| 41 | MP0002998_abnormal_bone_remodeling | 1.67761230 |
| 42 | MP0008469_abnormal_protein_level | 1.66698358 |
| 43 | MP0005310_abnormal_salivary_gland | 1.59340232 |
| 44 | MP0000604_amyloidosis | 1.56852245 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.55277831 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.55277831 |
| 47 | MP0000716_abnormal_immune_system | 1.52223537 |
| 48 | MP0004947_skin_inflammation | 1.51186560 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.49583017 |
| 50 | MP0003690_abnormal_glial_cell | 1.43731973 |
| 51 | MP0002398_abnormal_bone_marrow | 1.39033797 |
| 52 | MP0003828_pulmonary_edema | 1.38547848 |
| 53 | MP0000858_altered_metastatic_potential | 1.36629135 |
| 54 | MP0005166_decreased_susceptibility_to | 1.33147588 |
| 55 | MP0008004_abnormal_stomach_pH | 1.32562095 |
| 56 | MP0003448_altered_tumor_morphology | 1.28941271 |
| 57 | MP0000689_abnormal_spleen_morphology | 1.24706505 |
| 58 | MP0002429_abnormal_blood_cell | 1.17191769 |
| 59 | MP0003453_abnormal_keratinocyte_physiol | 1.12366984 |
| 60 | MP0000465_gastrointestinal_hemorrhage | 1.10012500 |
| 61 | MP0005451_abnormal_body_composition | 1.09624883 |
| 62 | MP0002722_abnormal_immune_system | 1.09425242 |
| 63 | MP0005167_abnormal_blood-brain_barrier | 1.04285875 |
| 64 | MP0003763_abnormal_thymus_physiology | 1.03374057 |
| 65 | MP0003879_abnormal_hair_cell | 1.03148610 |
| 66 | MP0006054_spinal_hemorrhage | 0.91755917 |
| 67 | MP0002277_abnormal_respiratory_mucosa | 0.91618059 |
| 68 | MP0005390_skeleton_phenotype | 0.91441355 |
| 69 | MP0002254_reproductive_system_inflammat | 0.90622258 |
| 70 | MP0009763_increased_sensitivity_to | 0.84839464 |
| 71 | MP0005164_abnormal_response_to | 0.83069626 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 0.82715668 |
| 73 | MP0004883_abnormal_blood_vessel | 0.82262311 |
| 74 | MP0001851_eye_inflammation | 0.79867783 |
| 75 | MP0000920_abnormal_myelination | 0.79298306 |
| 76 | MP0005319_abnormal_enzyme/_coenzyme | 0.78866402 |
| 77 | MP0003718_maternal_effect | 0.78193198 |
| 78 | MP0001663_abnormal_digestive_system | 0.77450996 |
| 79 | MP0003795_abnormal_bone_structure | 0.73423723 |
| 80 | MP0001873_stomach_inflammation | 0.72840778 |
| 81 | MP0003866_abnormal_defecation | 0.72799317 |
| 82 | MP0001542_abnormal_bone_strength | 0.71701772 |
| 83 | MP0010307_abnormal_tumor_latency | 0.71394670 |
| 84 | MP0000490_abnormal_crypts_of | 0.69571149 |
| 85 | MP0002132_abnormal_respiratory_system | 0.69400731 |
| 86 | MP0000703_abnormal_thymus_morphology | 0.68484205 |
| 87 | MP0005365_abnormal_bile_salt | 0.64558663 |
| 88 | MP0005647_abnormal_sex_gland | 0.63634087 |
| 89 | MP0003091_abnormal_cell_migration | 0.63004284 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.61990871 |
| 91 | MP0003329_amyloid_beta_deposits | 0.61900372 |
| 92 | MP0005165_increased_susceptibility_to | 0.60925705 |
| 93 | MP0002933_joint_inflammation | 0.60859399 |
| 94 | MP0008874_decreased_physiological_sensi | 0.57143673 |
| 95 | MP0000249_abnormal_blood_vessel | 0.54372868 |
| 96 | MP0005023_abnormal_wound_healing | 0.54144659 |
| 97 | MP0005076_abnormal_cell_differentiation | 0.52931095 |
| 98 | MP0005075_abnormal_melanosome_morpholog | 0.50028739 |
| 99 | MP0002396_abnormal_hematopoietic_system | 0.47032205 |
| 100 | MP0004808_abnormal_hematopoietic_stem | 0.46312790 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.53874240 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.53874240 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 6.53874240 |
| 4 | Abnormality of macrophages (HP:0004311) | 5.88213736 |
| 5 | Eczematoid dermatitis (HP:0000976) | 5.12706823 |
| 6 | Recurrent abscess formation (HP:0002722) | 5.09168554 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 5.01949596 |
| 8 | Loss of speech (HP:0002371) | 4.50165714 |
| 9 | Myositis (HP:0100614) | 4.41462279 |
| 10 | Increased cerebral lipofuscin (HP:0011813) | 4.34224360 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 4.28269481 |
| 12 | Dysostosis multiplex (HP:0000943) | 4.27756082 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.26059859 |
| 14 | Vacuolated lymphocytes (HP:0001922) | 4.24311328 |
| 15 | Stomatitis (HP:0010280) | 4.22692708 |
| 16 | Orchitis (HP:0100796) | 4.14915738 |
| 17 | Disinhibition (HP:0000734) | 4.14061505 |
| 18 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.94708650 |
| 19 | Optic neuritis (HP:0100653) | 3.92466694 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 3.92466694 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 3.77971638 |
| 22 | Mutism (HP:0002300) | 3.66493092 |
| 23 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.54491401 |
| 24 | Obstructive lung disease (HP:0006536) | 3.38857557 |
| 25 | Chronic obstructive pulmonary disease (HP:0006510) | 3.38857557 |
| 26 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.24578790 |
| 27 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.24578790 |
| 28 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.24578790 |
| 29 | Amyloidosis (HP:0011034) | 3.17805979 |
| 30 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.17608041 |
| 31 | Malnutrition (HP:0004395) | 3.03248504 |
| 32 | Spontaneous hematomas (HP:0007420) | 3.03077743 |
| 33 | Mucopolysacchariduria (HP:0008155) | 3.02050099 |
| 34 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.02050099 |
| 35 | Purpura (HP:0000979) | 3.01795676 |
| 36 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.95891398 |
| 37 | Petechiae (HP:0000967) | 2.91534454 |
| 38 | Meningitis (HP:0001287) | 2.90503681 |
| 39 | Recurrent skin infections (HP:0001581) | 2.90455940 |
| 40 | Axonal loss (HP:0003447) | 2.86847512 |
| 41 | Recurrent fungal infections (HP:0002841) | 2.83092106 |
| 42 | Autoimmune thrombocytopenia (HP:0001973) | 2.81906085 |
| 43 | Neurofibrillary tangles (HP:0002185) | 2.78239460 |
| 44 | Increased serum ferritin (HP:0003281) | 2.76965181 |
| 45 | Diminished motivation (HP:0000745) | 2.73066378 |
| 46 | Apathy (HP:0000741) | 2.72096582 |
| 47 | Pulmonary infiltrates (HP:0002113) | 2.71856950 |
| 48 | Glomerulonephritis (HP:0000099) | 2.71302312 |
| 49 | Gingivitis (HP:0000230) | 2.67889534 |
| 50 | Urticaria (HP:0001025) | 2.64163674 |
| 51 | Nuclear cataract (HP:0100018) | 2.62955109 |
| 52 | Progressive neurologic deterioration (HP:0002344) | 2.62564916 |
| 53 | Keratoconjunctivitis sicca (HP:0001097) | 2.61813906 |
| 54 | Vasculitis (HP:0002633) | 2.60445701 |
| 55 | Hepatosplenomegaly (HP:0001433) | 2.48402897 |
| 56 | Agnosia (HP:0010524) | 2.48165323 |
| 57 | Hemoptysis (HP:0002105) | 2.47961102 |
| 58 | Neuronal loss in central nervous system (HP:0002529) | 2.45544863 |
| 59 | Hematochezia (HP:0002573) | 2.39736303 |
| 60 | Encephalitis (HP:0002383) | 2.38373938 |
| 61 | Keratoconjunctivitis (HP:0001096) | 2.38298714 |
| 62 | Cellulitis (HP:0100658) | 2.37253748 |
| 63 | Increased IgE level (HP:0003212) | 2.37214217 |
| 64 | Upper motor neuron abnormality (HP:0002127) | 2.33255959 |
| 65 | Episodic fever (HP:0001954) | 2.26059068 |
| 66 | Abnormality of iron homeostasis (HP:0011031) | 2.23825012 |
| 67 | Osteomyelitis (HP:0002754) | 2.21629735 |
| 68 | Inappropriate behavior (HP:0000719) | 2.20793749 |
| 69 | Conjunctival telangiectasia (HP:0000524) | 2.20583649 |
| 70 | Polyneuropathy (HP:0001271) | 2.16861022 |
| 71 | Metaphyseal irregularity (HP:0003025) | 2.14075336 |
| 72 | Prolonged bleeding time (HP:0003010) | 2.14017409 |
| 73 | Pustule (HP:0200039) | 2.09319099 |
| 74 | Increased IgM level (HP:0003496) | 2.08918475 |
| 75 | Pulmonary embolism (HP:0002204) | 2.07989063 |
| 76 | Recurrent viral infections (HP:0004429) | 2.07707332 |
| 77 | Gastrointestinal infarctions (HP:0005244) | 2.06694181 |
| 78 | Memory impairment (HP:0002354) | 2.06360667 |
| 79 | Complement deficiency (HP:0004431) | 2.02040215 |
| 80 | Basal ganglia calcification (HP:0002135) | 2.01325720 |
| 81 | T lymphocytopenia (HP:0005403) | 2.01250754 |
| 82 | Inflammation of the large intestine (HP:0002037) | 1.99425578 |
| 83 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.99167419 |
| 84 | Recurrent cutaneous fungal infections (HP:0011370) | 1.96762711 |
| 85 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.96762711 |
| 86 | Epistaxis (HP:0000421) | 1.95242501 |
| 87 | Dementia (HP:0000726) | 1.94879331 |
| 88 | Recurrent pneumonia (HP:0006532) | 1.94109856 |
| 89 | Prolonged neonatal jaundice (HP:0006579) | 1.93533344 |
| 90 | Gastrointestinal inflammation (HP:0004386) | 1.92243160 |
| 91 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.92015325 |
| 92 | Anorexia (HP:0002039) | 1.91839776 |
| 93 | Supranuclear gaze palsy (HP:0000605) | 1.89670077 |
| 94 | Gangrene (HP:0100758) | 1.87668948 |
| 95 | Pathologic fracture (HP:0002756) | 1.86902035 |
| 96 | Premature loss of primary teeth (HP:0006323) | 1.86624257 |
| 97 | Personality changes (HP:0000751) | 1.86563531 |
| 98 | Abnormality of complement system (HP:0005339) | 1.86383882 |
| 99 | Leukocytosis (HP:0001974) | 1.86213858 |
| 100 | Cerebral inclusion bodies (HP:0100314) | 1.86178701 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.76476185 |
| 2 | MAP4K1 | 3.13643670 |
| 3 | BLK | 3.04314164 |
| 4 | MAP3K13 | 2.89944979 |
| 5 | ERN1 | 2.81883032 |
| 6 | IRAK4 | 2.71808607 |
| 7 | TYK2 | 2.47990569 |
| 8 | CSK | 2.42363390 |
| 9 | MAP2K3 | 2.40035607 |
| 10 | TGFBR2 | 2.23756959 |
| 11 | ARAF | 2.22992696 |
| 12 | MAP3K11 | 2.21439742 |
| 13 | TBK1 | 2.20976635 |
| 14 | IRAK3 | 2.17956501 |
| 15 | MAP3K14 | 2.17675303 |
| 16 | TNK2 | 2.17603155 |
| 17 | NME2 | 2.17278297 |
| 18 | MAP3K3 | 2.11871741 |
| 19 | TAOK2 | 1.94331958 |
| 20 | TAOK1 | 1.93427444 |
| 21 | FES | 1.92693658 |
| 22 | FGR | 1.87627213 |
| 23 | ZAP70 | 1.82330758 |
| 24 | PRPF4B | 1.73641410 |
| 25 | MATK | 1.72942725 |
| 26 | MOS | 1.71325831 |
| 27 | CSF1R | 1.70107143 |
| 28 | GRK7 | 1.68297471 |
| 29 | IKBKB | 1.63986648 |
| 30 | JAK3 | 1.60820527 |
| 31 | IKBKE | 1.57043254 |
| 32 | TXK | 1.49965052 |
| 33 | SYK | 1.46948524 |
| 34 | KIT | 1.36986220 |
| 35 | MAP3K9 | 1.35460172 |
| 36 | TESK2 | 1.33452996 |
| 37 | ACVR1B | 1.31023255 |
| 38 | LYN | 1.30342034 |
| 39 | TAOK3 | 1.28031208 |
| 40 | BTK | 1.26682810 |
| 41 | MAP3K1 | 1.26654082 |
| 42 | BMPR2 | 1.20423010 |
| 43 | HCK | 1.19444363 |
| 44 | GRK6 | 1.17757349 |
| 45 | MARK3 | 1.14474946 |
| 46 | LCK | 1.03547116 |
| 47 | CAMKK2 | 0.98751621 |
| 48 | BRAF | 0.94837165 |
| 49 | CDC42BPA | 0.93722900 |
| 50 | ABL2 | 0.93422861 |
| 51 | KSR2 | 0.87870386 |
| 52 | SIK3 | 0.87564980 |
| 53 | IRAK2 | 0.83648472 |
| 54 | JAK1 | 0.78591934 |
| 55 | STK10 | 0.76727119 |
| 56 | JAK2 | 0.75892136 |
| 57 | DDR2 | 0.74918152 |
| 58 | PDK1 | 0.74611834 |
| 59 | STK24 | 0.74140014 |
| 60 | MAP3K5 | 0.71835242 |
| 61 | PDPK1 | 0.69091618 |
| 62 | CAMK1D | 0.68095807 |
| 63 | TESK1 | 0.63139641 |
| 64 | PRKD2 | 0.62009236 |
| 65 | TEC | 0.61002895 |
| 66 | EPHB1 | 0.60894234 |
| 67 | RIPK1 | 0.60342787 |
| 68 | MARK2 | 0.59329613 |
| 69 | IRAK1 | 0.56055087 |
| 70 | PIM1 | 0.55819358 |
| 71 | ITK | 0.55647083 |
| 72 | CHUK | 0.55331609 |
| 73 | PIM2 | 0.54048899 |
| 74 | CDK19 | 0.52348668 |
| 75 | MAP3K8 | 0.50106664 |
| 76 | FYN | 0.46393505 |
| 77 | LRRK2 | 0.46356327 |
| 78 | MAPK12 | 0.43846575 |
| 79 | MAPK7 | 0.43778241 |
| 80 | TGFBR1 | 0.41385679 |
| 81 | MAP2K6 | 0.40772448 |
| 82 | RPS6KL1 | 0.38197550 |
| 83 | RPS6KC1 | 0.38197550 |
| 84 | SIK2 | 0.38105903 |
| 85 | MAPK4 | 0.35818354 |
| 86 | PRKCQ | 0.35566461 |
| 87 | MAP3K6 | 0.35536382 |
| 88 | CDK9 | 0.33383215 |
| 89 | ABL1 | 0.32070608 |
| 90 | DAPK2 | 0.30397486 |
| 91 | PRKG2 | 0.30077988 |
| 92 | KSR1 | 0.29785028 |
| 93 | TRIB3 | 0.27523924 |
| 94 | RPS6KA6 | 0.27315749 |
| 95 | CAMKK1 | 0.25972503 |
| 96 | RAF1 | 0.25649433 |
| 97 | PAK1 | 0.24632055 |
| 98 | MAPKAPK2 | 0.24344203 |
| 99 | RPS6KA2 | 0.24097398 |
| 100 | PRKCD | 0.23250554 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.26465828 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.25638119 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.10524981 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.82387462 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.69465261 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.64933584 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.44755103 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.42785712 |
| 9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.40940132 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.35788803 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.32809129 |
| 12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.28399406 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 2.25977282 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.10000862 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.00819608 |
| 16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.96924972 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.92018813 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.91833845 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.88897875 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.87177817 |
| 21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.82161387 |
| 22 | Phagosome_Homo sapiens_hsa04145 | 1.80817469 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.76397757 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.72510198 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.66751412 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.60256866 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.55992477 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.53627928 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.53386278 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.48124884 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.45571238 |
| 32 | Salmonella infection_Homo sapiens_hsa05132 | 1.45549962 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.42666291 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.40536785 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.40304973 |
| 36 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.32686353 |
| 37 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.31407528 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.30573696 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.28207336 |
| 40 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.19084033 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.17912525 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.17853592 |
| 43 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.16074934 |
| 44 | Measles_Homo sapiens_hsa05162 | 1.15377612 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.13930826 |
| 46 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.11337179 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 1.08845838 |
| 48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.08442716 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.04342034 |
| 50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.02865908 |
| 51 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96035251 |
| 52 | Prion diseases_Homo sapiens_hsa05020 | 0.85196622 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.84801780 |
| 54 | Hepatitis B_Homo sapiens_hsa05161 | 0.84357144 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 0.79237879 |
| 56 | Apoptosis_Homo sapiens_hsa04210 | 0.78339741 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 0.75719678 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75596084 |
| 59 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74585578 |
| 60 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.72153773 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69335565 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66450789 |
| 63 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66421425 |
| 64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.65326584 |
| 65 | Platelet activation_Homo sapiens_hsa04611 | 0.64525869 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 0.59071972 |
| 67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58807812 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56232827 |
| 69 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.55878841 |
| 70 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.55242629 |
| 71 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.54598172 |
| 72 | Bladder cancer_Homo sapiens_hsa05219 | 0.50478043 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48612851 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48157981 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46079827 |
| 76 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.45875102 |
| 77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.41916422 |
| 78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41213016 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38821046 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38482802 |
| 81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37368021 |
| 82 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35553081 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34011063 |
| 84 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.33701415 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.33461353 |
| 86 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32348324 |
| 87 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32292794 |
| 88 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.31685266 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | 0.31394157 |
| 90 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.31056889 |
| 91 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.30828035 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.27479777 |
| 93 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.27392638 |
| 94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.25805072 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24626152 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.21703564 |
| 97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.21557111 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.17652277 |
| 99 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.16345020 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13286637 |

